|
|
||||||||
Stem Cells, Vol 12, 278-288, Copyright © 1994 by AlphaMed Press
REVIEWS |
J Banchereau, F Briere, YJ Liu and F Rousset
Schering-Plough, Laboratory for Immunological Research, Dardilly, France.
During antigen driven immune responses, antigen-specific naive B lymphocytes undergo a cascade of events including activation, expansion, mutations, isotype switch, selections and differentiation into either antibody secreting plasma cells or memory B cells. These antigen-dependent events, which we propose to call immunopoiesis, occur in different areas of secondary lymphoid organs, as well as other nonlymphoid organs. B cells interact with antigens and numerous cell types (T cells, dendritic cells, follicular dendritic cells and macrophages) through numerous cell surface molecules and cytokines. B cells costimulated through their antigen receptor and cytokines such as interleukin 2 (IL-2), IL-4 and IL-10 undergo limited proliferation and differentiation into immunoglobulin (Ig) secreting cells. In contrast, crosslinking of the B cell CD40 antigen, a member of the tumor necrosis factor (TNF) receptor family, results in major cellular activation further modulated by cytokines. In particular, IL-4 and IL-13 permit establishment of long-term factor-dependent B cell lines, as well as isotype switch towards the production of IgE and IgG4. Addition of IL- 10 to CD40-activated B cells results in limited proliferation and remarkable differentiation into plasma cells. IL-10 also participates in isotype switch towards IgG1, IgG3 and IgA. The ligand for CD40, a member of the TNF family, is transiently expressed on activated T cells, and interrupted CD40/CD40-L interactions result in profoundly altered humoral immune responses.
This article has been cited by other articles:
![]() |
H. J. Kueng, V. M. Leb, D. Haiderer, G. Raposo, C. Thery, S. V. Derdak, K. G. Schmetterer, A. Neunkirchner, C. Sillaber, B. Seed, et al. General Strategy for Decoration of Enveloped Viruses with Functionally Active Lipid-Modified Cytokines J. Virol., August 15, 2007; 81(16): 8666 - 8676. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Kuo, A. L. Shaffer, J. Haddad Jr., Y. S. Choi, L. M. Staudt, and K. Calame Repression of BCL-6 is required for the formation of human memory B cells in vitro J. Exp. Med., April 16, 2007; 204(4): 819 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Langer, D. Langnickel, P. Enghard, R. Undeutsch, G. R. Burmester, F. Hiepe, A. Radbruch, and G. Riemekasten The systemic and SmD183-119-autoantigen-specific cytokine memory of Th cells in SLE patients Rheumatology, February 1, 2007; 46(2): 238 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Sheng, L. Li, B. B. Ganesh, C. Vasu, B. S. Prabhakar, and M. N. Meriggioli Suppression of Experimental Autoimmune Myasthenia Gravis by Granulocyte-Macrophage Colony-Stimulating Factor Is Associated with an Expansion of FoxP3+ Regulatory T Cells J. Immunol., October 15, 2006; 177(8): 5296 - 5306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Duddy, A. Alter, and A. Bar-Or Distinct Profiles of Human B Cell Effector Cytokines: A Role in Immune Regulation? J. Immunol., March 15, 2004; 172(6): 3422 - 3427. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Kim, K. Nagata, and E. C. Butcher Dendritic Cells Support Sequential Reprogramming of Chemoattractant Receptor Profiles During Naive to Effector T Cell Differentiation J. Immunol., July 1, 2003; 171(1): 152 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Lutz, M. Schnare, M. Menges, S. Rossner, M. Rollinghoff, G. Schuler, and A. Gessner Differential Functions of IL-4 Receptor Types I and II for Dendritic Cell Maturation and IL-12 Production and Their Dependency on GM-CSF J. Immunol., October 1, 2002; 169(7): 3574 - 3580. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Tejada-Simon, Y. C. Q. Zang, J. Hong, V. M. Rivera, J. M. Killian, and J. Z. Zhang Detection of Viral DNA and Immune Responses to the Human Herpesvirus 6 101-Kilodalton Virion Protein in Patients with Multiple Sclerosis and in Controls J. Virol., May 13, 2002; 76(12): 6147 - 6154. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
